are liraglutide and semaglutide the same Peptide mapping analysis of synthetic for generic development of drugs originating from recombinant DNA technology Semaglutide Vs Liraglutide | Wegovy

Originally developed to treat type 2 diabetes, GLP-1 medications are now widely prescribed for weight loss

What is cagrilintide and how does it differ from semaglutide Cagrilintide: Long-acting amylin analog What cagrilintide is: Synthetic analog of amylin (human hormone) Long-acting formulation (weekly dosing) Developed by Novo Nordisk Currently in Phase 3 clinical trials Not yet FDA approved (as of 2024) Paired with semaglutide as "CagriSema" How amylin works naturally: Co-secreted with insulin from pancreatic beta cells Released after meals Slows gastric emptying (food stays in stomach longer) Reduces glucagon secretion Signals satiety to brain Regulates postprandial glucose Cagrilintide's mechanisms: Mimics natural amylin but lasts much longer Dramatically slows gastric emptying Increases satiety and fullness Reduces food intake Lowers postprandial glucose Works on amylin receptors (different from GLP-1) Primary benefits: Powerful appetite suppression Extended feeling of fullness Reduced meal frequency Lower caloric intake Glucose regulation Complements GLP-1 action Learn about peptides , how peptides work , and what are peptides used for in our foundational guides

Frias JP, Deenadayalan S, et al

Schedule: Daily subcutaneous administration for 812 weeks, with an optional extension up to 16 weeks

Consult a licensed healthcare provider regarding your individual health circumstances